Genetic Analysis AS (GA) is positioned to become a world leader within the field of molecular diagnostics of diseases related to gut imbalances. By utilizing the DNA-based GA-map™ array technology, profiles of a patient’s gut microbiota is quickly generated and can be related to various health conditions.
Feb 21 2013 : Aiming for 2013 CE Certification for new GA-map™ IBS test, Genetic Analysis appoints Kari Stenersen as new CEO
Nov 9 2012 : Genetic Analysis AS will present a poster at 2012 Advances in Inflammatory Bowel Disease in Hollywood, Florida, 13 - 15 December 2012.
Oct 1 2012 : The European Commission has awarded a grant to the IBD-Character consortium of which Genetic Analysis AS is a partner.